Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
Clinical trial NCT02661464 · TERMINATED
Trial details
- NCT number
- NCT02661464
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2021-12-13
- Enrollment
- 677
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.